cl075 Search Results


cl 075  (Bio-Techne corporation)
90
Bio-Techne corporation cl 075
Cl 075, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/custom%406142%4030930145?v=Bio-Techne+corporation
Average 90 stars, based on 1 article reviews
cl 075 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cl075  (Tocris)
93
Tocris cl075
Cl075, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/pm40615103-110-36-56?v=Tocris
Average 93 stars, based on 1 article reviews
cl075 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
synthetic thiazoloquinoline immunostimulatory compound cl075  (Helmholtz Zentrum fur Infektionsforschung GmbH)
90
Helmholtz Zentrum fur Infektionsforschung GmbH synthetic thiazoloquinoline immunostimulatory compound cl075
Synthetic Thiazoloquinoline Immunostimulatory Compound Cl075, supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/pm20511554-32-12-79?v=Helmholtz+Zentrum+fur+Infektionsforschung+GmbH
Average 90 stars, based on 1 article reviews
synthetic thiazoloquinoline immunostimulatory compound cl075 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cl075:ag85bp25-ps containing approximately 8 to 10 μg of ag85b/p25  (Biomatik)
90
Biomatik cl075:ag85bp25-ps containing approximately 8 to 10 μg of ag85b/p25
CL075:Ag85Bp25-PS and BCG induce comparable <t>Ag85B-specific</t> CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.
Cl075:Ag85bp25 Ps Containing Approximately 8 To 10 μg Of Ag85b/P25, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/pmc05667586-43-33-34?v=Biomatik
Average 90 stars, based on 1 article reviews
cl075:ag85bp25-ps containing approximately 8 to 10 μg of ag85b/p25 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cl075 (3 mg/ml)  (SAS institute)
90
SAS institute cl075 (3 mg/ml)
CL075:Ag85Bp25-PS and BCG induce comparable <t>Ag85B-specific</t> CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.
Cl075 (3 Mg/Ml), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/10__1158_slash_0008___5472__can___12___3058-49-12-20?v=SAS+institute
Average 90 stars, based on 1 article reviews
cl075 (3 mg/ml) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cl075 (tlr8)  (Vivogen Biotechnology Inc)
90
Vivogen Biotechnology Inc cl075 (tlr8)
CL075:Ag85Bp25-PS and BCG induce comparable <t>Ag85B-specific</t> CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.
Cl075 (Tlr8), supplied by Vivogen Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/pm36203578-48-14-18?v=Vivogen+Biotechnology+Inc
Average 90 stars, based on 1 article reviews
cl075 (tlr8) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
polymersome nanocarrier encapsulating cl075  (NanoCarrier Co)
90
NanoCarrier Co polymersome nanocarrier encapsulating cl075
CL075:Ag85Bp25-PS and BCG induce comparable <t>Ag85B-specific</t> CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.
Polymersome Nanocarrier Encapsulating Cl075, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cl075/10__1016_slash_j__ejmech__2020__112238-470-1-2?v=NanoCarrier+Co
Average 90 stars, based on 1 article reviews
polymersome nanocarrier encapsulating cl075 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cl075  (MedChemExpress)
N/A
   Buy from Supplier
cl 075  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier
cl075  (TargetMol)
N/A
   Buy from Supplier
cl075  (BOC Sciences)
N/A
A thiazoloquinolone derivative that stimulates TLR8 in human peripheral blood mononuclear cells
   Buy from Supplier
cl075  (InvivoGen)
N/A
Thiazoloquinoline compound
   Buy from Supplier

Image Search Results


CL075:Ag85Bp25-PS and BCG induce comparable Ag85B-specific CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.

Journal: The Journal of Allergy and Clinical Immunology

Article Title: Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses

doi: 10.1016/j.jaci.2016.12.985

Figure Lengend Snippet: CL075:Ag85Bp25-PS and BCG induce comparable Ag85B-specific CD4 + effector T cells in the spleens of neonatal huTLR8Tg mice. A, Experimental design: 7-day-old huTLR8Tg and matched littermate WT mice were immunized subcutaneously and killed 14 days later before harvesting spleens and staining splenocytes with a control versus Ag85B 280–294 MHCII tetramer and for surface marker expression. B, Representative flow cytometric plots showing Tet + T cells as CD44 + Neg Tet + or CD44 + Ag85B Tet + cells gated on live CD4 + splenic lymphocytes of BCG- or CL075-Ag85Bp25-PS–vaccinated mice 2 weeks after immunization. C and D, Similar to BCG, CL075-Ag85Bp25-PS induced a significant increase in CD44 + Ag85B Tet + cells compared with CD44 + Neg Tet + cells. Results represent means ± SEMs (n = 14-15), with significance relative to unspecific control tetramer. E, Neonatal humanized TLR8 mice have greater numbers of splenic Ag85B-specific CD4 + T cells versus their WT littermates. The unpaired Mann-Whitney test was applied, and statistical significance was denoted as follows: ** P < .01 and *** P < .001. NS , Not significant.

Article Snippet: Mice were immunized subcutaneously at the scruff of the neck with either 0.2 × 10 6 colony-forming units of BCG (Organon Teknika/Merck, Durham, NC) or CL075:Ag85Bp25-PS containing approximately 8 to 10 μg of Ag85B/p25 (Biomatik, Cambridge, Ontario, Canada) and approximately 0.1 mg/kg CL075 in a total volume of 25 μL.

Techniques: Staining, Marker, Expressing, MANN-WHITNEY